PRRT2 and melanoma: RIPK4 is a key element of the Wnt/b-catenin signaling pathways [32] or PKC/NFkappaB [23,27,33] signaling pathways, which are important for melanoma cell biology and may therefore serve as a ‘bypass’ mechanism for drug resistance [34,35].